Through our in vivo CRISPR screen targeting DDR genes in a MYC-induced and p53-deficient breast cancer model, we discovered an unexpected role for MRE11 as a direct stimulator of cGAS-dependent innate immune activation by oncogene-induced DNA damage. Here, CGAS is linked to breast carcinoma.